As illustrated in Fig. 3A, we treated both naïve (non‐tumor‐bearing) mice and mice bearing murine 5TGM1 myeloma cells with anti‐LRP6 antibody twice weekly and measured bone structural changes by μCT analysis (Fig. 3B–D). Here, LRP6 is linked to neoplasm.